Hemoglobin A1c Testing Devices Global Market Expected to Reach $2.94 Billion By 2028 with CAGR of 11.1% | Arkray Inc., Abbott Laboratories, Menarini Group, Tosoh Corporation, Trinity Biotech PLC

The Hemoglobin A1c Testing Devices by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Hemoglobin A1c Testing Devices Market:
https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-testing-devices-global-market-report

According to The Business Research Company’s Hemoglobin A1c Testing Devices, the hemoglobin a1c testing devices market size has grown rapidly in recent years. It will grow from $1.73 billion in 2023 to $1.93 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to holistic diabetes management programs, continuous innovation, improvement in healthcare infrastructure, preventive healthcare practices, home healthcare trends.

The hemoglobin a1c testing devices market size is expected to see rapid growth in the next few years. It will grow to $2.94 billion in 2028 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to point-of-care testing expansion, home testing and self-monitoring, focus on preventive healthcare, increasing aging population, healthcare accessibility expansion. Major trends in the forecast period include continuous innovation and cost efficiency, rising diabetes prevalence, shift towards point-of-care testing, technological advancements, home healthcare and self-monitoring.

The rising prevalence of diabetes is expected to propel the growth of the hemoglobin A1c testing devices market. Diabetes is a chronic metabolic disorder that elevates blood glucose levels. Hemoglobin A1c testing is used in providing information on average blood glucose levels in individuals that are used in the diagnosis of type 2 diabetes, pre-diabetes, and diabetes management, which enables the individuals to monitor the disease and help make treatment decisions to prevent complications. For instance, in 2022, Centers for Disease Control and Prevention, a US-based national public health agency, around 37.3 million people were suffering from diabetes which equals 11.3% of the United States population. Additionally, in December 2021, according to the International Diabetes Federation, a Belgium-based global diabetes community, approximately 537 million adults were suffering from diabetes globally, whereas 3 out of 4 adults are in low- and middle-income countries. Therefore, the increased cases of diabetes patients will drive the hemoglobin A1c testing devices market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9077&type=smp

The hemoglobin a1c testing devices market covered in this report is segmented –
1) By Type: Bench Top Device, Handheld Device
2) By Technology: Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay, Other Technologies
3) By End Use: Hospitals, Pharmaceuticals, Medical Devices, Laboratory Testing

Product innovations are a key trend in gaining popularity in the hemoglobin A1c testing devices market. Major companies operating in the market are focused on developing innovative products to strengthen their position in the market. For instance, in June 2021, Trivitron Healthcare Pvt. Ltd., an India-based medical device company, introduced NANO H5 and NANO H110, advanced diagnostic solutions for HbA1c based on HPLC technology to provide a result within 130 seconds. NANO H5 and NANO H110 are compact, automated HPLC analyzers that use ion exchange liquid chromatography to quantitatively determine glycated hemoglobin (HbA1c) in a human whole blood sample. NANO H5 and NANO H110 can process samples up to 5 and 110, respectively. NANO H110 offers advanced facilities such as a barcode scanner and cap piercing with a high sample loading capacity, making the device suitable for medium to large laboratories.

The hemoglobin a1c testing devices market report table of contents includes:
1. Executive Summary